Evidence-Based Framework for Safe Calorie Intake on GLP-1 Safe GLP-1 dosing requires maintaining adequate protein, micronutrient density, and total energy to prevent lean muscle loss and nutrient deficiencies
Common adverse effects include nausea, vomiting, diarrhea, and constipation, which are generally dose-dependent and often improve with continued use
doi: 10.1038/s42255-023-00966-w 62 NovikoffAMullerTD
The key to getting the most out of BPC-157 therapy is working with a qualified provider who uses human-grade medications, builds a personalized protocol, and supports your progress with the right nutritional guidance along the way
2016;2016:e6757154
No lethal dose has been established in animal studies, even at dosages many orders of magnitude higher than those used in therapeutic research